Postoperative Nausea Clinical Trial
Official title:
Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia
The purpose of this study is to determine if intravenous fosaprepitant can interfere with nervous system monitoring signals in patients having surgery under general anesthesia. This medication has numerous effects on the sensory nerve transmission which can theoretically have effects on the ability to accurately measure somatosensory evoked potentials.
The purpose of this study is to determine if intravenous fosaprepitant can interfere with nervous system monitoring signals in patients having surgery under general anesthesia. Fosaprepitant is a drug commonly used to prevent post-operative nausea and vomiting, and works by inhibiting "substance P", which is found in the brain and spinal cord. Theoretically, fosaprepitant could interfere with nervous system recordings because of its effect on substance P,but it is not known if this actually occurs. The drug will be given after the patient has been anesthetized but before surgical incision so that if there are any changes on the intraoperative neuromonitoring signals they can only be attributed to fosaprepitant. If fosaprepitant alters intraoperative neuromonitoring signals during surgical procedures under general anesthesia, it would be important because anesthesiologist's who administer this drug would want to give it at the beginning of surgery when changes in intraoperative neuromonitoring signals would be unlikely to mean that these changes were due to surgical damage to the nervous system. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03639012 -
Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy
|
N/A | |
| Not yet recruiting |
NCT01389570 -
Postoperative Nausea/Vomiting and Acupressure
|
Phase 2 | |
| Completed |
NCT00830089 -
Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery
|
N/A | |
| Terminated |
NCT05112575 -
Evaluation of Patient Stress Level Caused by Radiological Investigations in Early Postoperative Phase After Craniotomy
|
||
| Completed |
NCT04759079 -
The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy
|
N/A | |
| Active, not recruiting |
NCT03712891 -
Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU
|
N/A | |
| Completed |
NCT01834898 -
Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery
|
N/A | |
| Completed |
NCT03631004 -
Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT05618236 -
Sugammadex and Neostigmine in Pediatric Patients
|
||
| Not yet recruiting |
NCT05632224 -
Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery
|
Phase 4 | |
| Completed |
NCT01020903 -
Aprepitant for Post-operative Nausea
|
N/A | |
| Completed |
NCT00793663 -
Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia
|
Phase 4 | |
| Completed |
NCT03503292 -
Pharmacogenomics and Post-Operative Nausea and Vomiting
|
Phase 4 | |
| Completed |
NCT05841693 -
Quality of Recovery in Parturients Consumed Preoperative Carbohydrate Fluid for Elective Cesarean Delivery
|
Phase 4 | |
| Completed |
NCT04742660 -
The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting
|
N/A | |
| Completed |
NCT03100669 -
Implementing a Postoperative MIRP (Minimally Invasive Repair of Pectus) Program Via Tele-monitoring
|
||
| Terminated |
NCT02765750 -
Postoperative Outcomes After Positive Intraoperative Messages
|
N/A | |
| Terminated |
NCT01798316 -
IV Acetaminophen for Postoperative Analgesia
|
Phase 4 | |
| Completed |
NCT03387956 -
Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting
|
N/A | |
| Completed |
NCT04718727 -
Olanzapine for the Prevention of Postoperative Nausea and Vomiting
|
Phase 1/Phase 2 |